Sally C. Pipes
Commentary
Medicare Turns 60 This Month: It’s Time for an Intervention
On July 30, Medicare will mark its 60th birthday. Like many 60-year-olds, it’s in the throes of a midlife crisis. But unlike a harmless convertible purchase or spontaneous trip to Paris, this one midlife crisis threatens the nation’s fiscal health — and the well-being of future retirees. Read the entire ...
Commentary
Thank Obamacare for America’s insurance fraud boom
The number of Americans enrolled in marketplace plans either fraudulently or improperly reached 6.4 million in 2025 — an increase of more than one-quarter, according to an analysis published last month by the Paragon Health Institute. All of this wrongdoing will cost American taxpayers an estimated $27 billion this year. ...
Commentary
Feds right to curtail California’s Medicaid scam
On Independence Day, President Trump signed the One Big Beautiful Bill Act, which is projected to reduce enrollment in Medicaid programs throughout the country, including Medi-Cal in California. But Californians should cheer, not jeer, these coverage “losses.” The law will primarily disenroll people who should have never been covered by ...
Commentary
Let’s talk about medical debt
A federal judge this month tossed out a Biden-era rule that would have wiped medical debt from consumers’ credit reports. The decision is a victory for borrowers and lenders alike. The now-defunct rule could have ended up hurting the very low-income individuals it was meant to help. Read the entire ...
Commentary
Trump Must Shut Down Counterfeit Weight-Loss Drugs
Americans looking to lose weight are increasingly turning to the internet. And they’re being duped. Telehealth startups and fly-by-night pharmacies are peddling what look like cheap, convenient versions of blockbuster drugs like Ozempic and Wegovy. But many of these offerings are neither authentic nor safe. They’re “compounded” copies — knockoffs ...
Commentary
The Big Beautiful Bill Fixes One Drug Problem—But Highlights An Even Bigger One
Buried within the One Big Beautiful Bill Act, which President Donald Trump signed into law July 4, is a provision that could improve or even save the lives of the 30 million Americans suffering from rare diseases. That provision is the Orphan Cures Act, which exempts certain drugs that treat ...
Commentary
One Big Beautiful Bill: A Fiscal Lifeline for Medicaid, Taxpayers
The “One Big Beautiful Bill” Act (OBBBA) signed into law by President Donald Trump on July 4 is set to help pull America’s healthcare system back from the brink of fiscal disaster. Read the entire op-ed here.
Commentary
The Culprit Impeding Drug Competition Is Not Who The Feds Expected
The Federal Trade Commission and U.S. Department of Justice recently kicked off a series of listening sessions to examine barriers to competition in the drug industry. The title of the first session—”Anticompetitive Conduct by Pharmaceutical Companies”—made it seem that regulators would chiefly investigate biotech firms. Yet by the end, panelists ...
Commentary
No, Donald Trump didn’t just slash Medicaid
Republicans’ One Big Beautiful Bill Act is now law. Democrats have wasted no time accusing the GOP of enshrining devastating “cuts” to Medicaid, the joint federal-state entitlement that provides health coverage for low-income Americans. That’s rubbish. The measure takes steps to restrain Medicaid’s rampant growth in recent years so that ...
Commentary
Cheap Drugs from Canada Can’t Make America Healthy
The U.S. Food and Drug Administration just announced plans to help states and Indian tribes purchase certain prescription drugs from Canada, where brand-name medicines tend to be cheaper because the government caps their price. The new guidance is part of a larger Trump administration effort to cut drug prices for ...
Medicare Turns 60 This Month: It’s Time for an Intervention
On July 30, Medicare will mark its 60th birthday. Like many 60-year-olds, it’s in the throes of a midlife crisis. But unlike a harmless convertible purchase or spontaneous trip to Paris, this one midlife crisis threatens the nation’s fiscal health — and the well-being of future retirees. Read the entire ...
Thank Obamacare for America’s insurance fraud boom
The number of Americans enrolled in marketplace plans either fraudulently or improperly reached 6.4 million in 2025 — an increase of more than one-quarter, according to an analysis published last month by the Paragon Health Institute. All of this wrongdoing will cost American taxpayers an estimated $27 billion this year. ...
Feds right to curtail California’s Medicaid scam
On Independence Day, President Trump signed the One Big Beautiful Bill Act, which is projected to reduce enrollment in Medicaid programs throughout the country, including Medi-Cal in California. But Californians should cheer, not jeer, these coverage “losses.” The law will primarily disenroll people who should have never been covered by ...
Let’s talk about medical debt
A federal judge this month tossed out a Biden-era rule that would have wiped medical debt from consumers’ credit reports. The decision is a victory for borrowers and lenders alike. The now-defunct rule could have ended up hurting the very low-income individuals it was meant to help. Read the entire ...
Trump Must Shut Down Counterfeit Weight-Loss Drugs
Americans looking to lose weight are increasingly turning to the internet. And they’re being duped. Telehealth startups and fly-by-night pharmacies are peddling what look like cheap, convenient versions of blockbuster drugs like Ozempic and Wegovy. But many of these offerings are neither authentic nor safe. They’re “compounded” copies — knockoffs ...
The Big Beautiful Bill Fixes One Drug Problem—But Highlights An Even Bigger One
Buried within the One Big Beautiful Bill Act, which President Donald Trump signed into law July 4, is a provision that could improve or even save the lives of the 30 million Americans suffering from rare diseases. That provision is the Orphan Cures Act, which exempts certain drugs that treat ...
One Big Beautiful Bill: A Fiscal Lifeline for Medicaid, Taxpayers
The “One Big Beautiful Bill” Act (OBBBA) signed into law by President Donald Trump on July 4 is set to help pull America’s healthcare system back from the brink of fiscal disaster. Read the entire op-ed here.
The Culprit Impeding Drug Competition Is Not Who The Feds Expected
The Federal Trade Commission and U.S. Department of Justice recently kicked off a series of listening sessions to examine barriers to competition in the drug industry. The title of the first session—”Anticompetitive Conduct by Pharmaceutical Companies”—made it seem that regulators would chiefly investigate biotech firms. Yet by the end, panelists ...
No, Donald Trump didn’t just slash Medicaid
Republicans’ One Big Beautiful Bill Act is now law. Democrats have wasted no time accusing the GOP of enshrining devastating “cuts” to Medicaid, the joint federal-state entitlement that provides health coverage for low-income Americans. That’s rubbish. The measure takes steps to restrain Medicaid’s rampant growth in recent years so that ...
Cheap Drugs from Canada Can’t Make America Healthy
The U.S. Food and Drug Administration just announced plans to help states and Indian tribes purchase certain prescription drugs from Canada, where brand-name medicines tend to be cheaper because the government caps their price. The new guidance is part of a larger Trump administration effort to cut drug prices for ...
